The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

A Colne man who lost his football scholarship in America due to a ketamine addiction is warning people about the dangers of ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Jeni Larmour died after taking ketamine on her first night at Newcastle University back in September 2020. Sandra Larmour, Jeni’s mum, is now calling for the reclassification of the drug, claiming ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...

It is a hallucinogenic drug, and is a controlled substance designed for use as an aesthetics. It also has now been touted for ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

A fatal medication error and subsequent involuntary manslaughter charge highlights the ongoing challenges of error reporting in EMS ...

Police raided a luxury condominium in Bangkok and arrested a Thai couple for producing and distributing a new narcotic known as Pod K.